Clinical Trials on Glabellar Crease

Total 10000 results

Fudan University

Unknown

Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial (NVBOX)

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Cancer Research Network
Sanofi

Unknown

Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery

Breast Cancer

United States
West China Hospital

Enrolling by invitation

Influencing Factors and Mechanisms of Capsular Contracture After Prosthesis Reconstruction in Patients With Breast Cancer

Breast Reconstruction | Breast Cancer Females

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Triple-Negative Breast Cancer (TNBC)

China
Mayo Clinic

Recruiting

Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer

Breast Carcinoma | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Suspended

Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma

United States
Georgetown University
Pfizer

Completed

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast Cancer

United States
Jonsson Comprehensive Cancer Center
Breast Cancer Research Foundation; MetVital, Inc.

Completed

Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditions

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditions

United States
Institut Cancerologie de l'Ouest

Not yet recruiting

Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease (ARTEMIS)

Breast Cancer

France
Fudan University

Not yet recruiting

RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure (BRIGHT)

Metastatic Breast Cancer | HER2-positive Breast Cancer
Atlas University

Recruiting

PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer (PTEN-miR-MBC)

Breast Cancer | Metastatic Breast Cancer | miRNAs | PTEN

Turkey (Türkiye)
Istituti Clinici Scientifici Maugeri SpA
ASST Fatebenefratelli Sacco; Università degli Studi di Brescia; Buzzi Children... and other collaborators

Recruiting

Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy (PDO-Neo01)

Invasive Breast Cancer

Italy
MedSIR

Recruiting

Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer (CADILLAC)

Breast Cancer | Hormon Receptor Positive Breast Cancer

Spain, Germany
Henan Cancer Hospital

Not yet recruiting

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

Breast Cancer | HER2 + Breast Cancer

China
Shuangyue Liu

Not yet recruiting

Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC

Breast Cancer - Female
The First Affiliated Hospital with Nanjing Medical...
Zhejiang Cancer Hospital; RenJi Hospital; The First Hospital of Jilin University and other collaborators

Recruiting

RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

HER2 + Breast Cancer

China
Henan Cancer Hospital

Recruiting

Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation

Breast Cancer Patients

China
Henan Cancer Hospital

Recruiting

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

Breast Cancer Patients

China
Taizhou Hospital

Not yet recruiting

Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

Breast Cancer Screening

China
Nevsehir Haci Bektas Veli University

Not yet recruiting

A Mindfulness-Based Self-Compassion Program

Breast Cancer Survivor

Turkey
Hunan Cancer Hospital

Recruiting

Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .

HR+ Breast Cancer

China
Health Hope Pharma

Not yet recruiting

Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer

Metastatic Breast Cancer
Henan Cancer Hospital

Recruiting

NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.

Breast Cancer Invasive

China
Shanghai Jiao Tong University School of Medicine

Recruiting

GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer (GzmB-PET4BC)

Breast Cancer Invasive

China
Shenzhen Celconta Life Science Co., Ltd.

Recruiting

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

Advanced Breast Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Breast Cancer Invasive

China
University of Oklahoma
American Cancer Society, Inc.

Recruiting

Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer (SDOTS)

Breast Cancer Survivor

United States
The First Affiliated Hospital with Nanjing Medical...
Affiliated Hospital of Jiangnan University; Yidu Central Hospital of Weifang; The Affiliated Jiangyin Hospital of Southeast University Medical College

Recruiting

Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)

Advanced Breast Cancer

China
Stemline Therapeutics, Inc.

Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

Advanced Breast Cancer

United States, Spain
Priyanka Sharma

Recruiting

HER2-positive Breast Cancer Registry (PRO-HER2)

HER2 + Breast Cancer

United States
Jiangsu Famous Medical Technology Co., Ltd.

Not yet recruiting

Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer

HER2+ Breast Cancer
The University of Texas Health Science Center,...
National Institute on Aging (NIA); National Center for Advancing Translational...

Recruiting

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Breast Cancer Survivorship

United States
Karolinska Institutet

Recruiting

To Live Better After Breast Cancer Treatment

Breast Cancer Survivorship

Sweden
Breast Cancer Trials, Australia and New Zealand

Recruiting

Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE) (PROSPECTIVE)

Breast Cancer | Breast Cancer Female

Australia, United States
AstraZeneca

Recruiting

Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling. (Pangeia-2)

Metastatic Breast Cancer

Brazil
AstraZeneca

Recruiting

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer (EvoPAR-BR01)

Advanced Breast Cancer

China, United States, Spain, Germany, Italy, Peru, United Kingdom, France, Brazil, Malaysia, Taiwan, Thailand, Hungary, Israel, Australia, Austria, Canada, Bulgaria, India, Japan, Poland, Czechia, Portugal, Hong Kong, Argentina, Puerto Rico, Chi... and more
American Society of Clinical Oncology
Patient-Centered Outcomes Research Institute

Recruiting

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Metastatic Breast Cancer

United States
The First Affiliated Hospital with Nanjing Medical...
Zhejiang Cancer Hospital

Recruiting

Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer

Advanced Breast Cancer

China
University of Southern California
National Cancer Institute (NCI)

Recruiting

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

Breast Carcinoma

United States
RenJi Hospital

Recruiting

Dalpiciclib in HR+/HER2- ABC

Advanced Breast Cancer

China
Erasmus Medical Center
University Medical Center Groningen; Leiden University Medical Center

Recruiting

FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test (FUTURE)

Advanced Breast Cancer

Netherlands
RenJi Hospital

Not yet recruiting

A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in Ultrasonography

Breast Cancer | Breast Cancer Diagnosis
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

Metastatic Breast Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Breast Cancer Resiliency Through Exercise Program (B-REP) (B-REP)

Breast Cancer Female

United States
Ataturk University

Recruiting

Tele-nursing Practices Based on Technological Competence Theory in Breast Cancer Patients

Breast Cancer Female

Turkey
University Medical Center Groningen
Martini Hospital Groningen

Recruiting

Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study (MARGIN-2)

Breast Cancer | Breast Cancer Invasive

Netherlands
RenJi Hospital

Recruiting

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer (CORINNE-PI)

Breast Cancer Invasive

China

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations